Literature DB >> 33431510

Using Mendelian Randomization to Improve the Design of Randomized Trials.

Brian A Ference1, Michael V Holmes2, George Davey Smith3.   

Abstract

Randomized controlled trials and Mendelian randomization studies are two study designs that provide randomized evidence in human biological and medical research. Both exploit the power of randomization to provide unconfounded estimates of causal effect. However, randomized trials and Mendelian randomization studies have very different study designs and scientific objectives. As a result, despite sometimes being referred to as "nature's randomized trial," a Mendelian randomization study cannot be used to replace a randomized trial but instead provides complementary information. In this review, we explain the similarities and differences between randomized trials and Mendelian randomization studies, and suggest several ways that Mendelian randomization can be used to directly inform and improve the design of randomized trials illustrated with practical examples. We conclude by describing how Mendelian randomization studies can employ the principles of trial design to be framed as "naturally randomized trials" that can provide a template for the design of future randomized trials evaluating therapies directed against genetically validated targets.
Copyright © 2021 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33431510      PMCID: PMC8247560          DOI: 10.1101/cshperspect.a040980

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  6 in total

Review 1.  Review of Mendelian Randomization Studies on Endometrial Cancer.

Authors:  Jian-Zeng Guo; Qi-Jun Wu; Fang-Hua Liu; Chang Gao; Ting-Ting Gong; Gang Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-09       Impact factor: 6.055

Review 2.  Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development.

Authors:  Michael V Holmes; Tom G Richardson; Brian A Ference; Neil M Davies; George Davey Smith
Journal:  Nat Rev Cardiol       Date:  2021-03-11       Impact factor: 32.419

3.  Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.

Authors:  Tom G Richardson; Genevieve M Leyden; Qin Wang; Joshua A Bell; Benjamin Elsworth; George Davey Smith; Michael V Holmes
Journal:  PLoS Biol       Date:  2022-02-25       Impact factor: 8.029

Review 4.  Integrating the Biology of Cardiovascular Disease into the Epidemiology of Economic Decision Modelling via Mendelian Randomisation.

Authors:  Zanfina Ademi; Jedidiah I Morton; Danny Liew; Stephen J Nicholls; Sophia Zoungas; Brian A Ference
Journal:  Pharmacoeconomics       Date:  2022-08-25       Impact factor: 4.558

Review 5.  Crosstalk between Statins and Cancer Prevention and Therapy: An Update.

Authors:  Beniamin Oskar Grabarek; Dariusz Boroń; Emilia Morawiec; Piotr Michalski; Veronica Palazzo-Michalska; Łukasz Pach; Barbara Dziuk; Magdalena Świder; Nikola Zmarzły
Journal:  Pharmaceuticals (Basel)       Date:  2021-11-25

6.  Role of the Microbiome in Regulating Bone Metabolism and Susceptibility to Osteoporosis.

Authors:  Owen Cronin; Susan A Lanham-New; Bernard M Corfe; Celia L Gregson; Andrea L Darling; Kourosh R Ahmadi; Philippa S Gibson; Jon H Tobias; Kate A Ward; Maria H Traka; Megan Rossi; Claire Williams; Nicholas C Harvey; Cyrus Cooper; Kevin Whelan; André G Uitterlinden; Paul W O'Toole; Claes Ohlsson; Juliet E Compston; Stuart H Ralston
Journal:  Calcif Tissue Int       Date:  2021-12-06       Impact factor: 4.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.